ID
41731
Descrição
Study ID: 111582 Clinical Study ID: 111582 Study Title: An Open Label Study to Examine the Effects of Low-fat and High-fat Meals on the Pharmacokinetics of Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00821054 https://clinicaltrials.gov/ct2/show/NCT00821054 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Lapatinib Trade Name: N/A Study Indication: Neoplasms, Breast The study consists of a screening, four study visits at day-1, week 1, 2 and 3 and a follow-up visit. This document documents any repeating Pharmacokinetics Blood measurements.
Link
https://clinicaltrials.gov/ct2/show/NCT00821054
Palavras-chave
Versões (1)
- 09/01/2021 09/01/2021 -
Titular dos direitos
GlaxoSmithKline
Transferido a
9 de janeiro de 2021
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Effects of Low-fat and high-fat meals on the Pharmacokinetics of Lapatinib in ErB2+ Breast Cancer patients, NCT00821054
Pharmacokinetics Repeat
- StudyEvent: ODM
Similar models
Pharmacokinetics Repeat
- StudyEvent: ODM
C0005767 (UMLS CUI-2)
C0205341 (UMLS CUI-3)
C2348184 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C1264639 (UMLS CUI [1,2])